Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world
The chemotherapy results have been analyzed in tuberculosis patients suffering from multiple drug resistance registered for treatment in the Russian Federation in 2011-2012 compared with the treatment outcomes of MDR patients registered for treatment in the world, BRICS and countries of the former S...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2016-01-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/838 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223492681695232 |
|---|---|
| author | S. A. Sterlikov V. V. Testov I. A. Vasilieva |
| author_facet | S. A. Sterlikov V. V. Testov I. A. Vasilieva |
| author_sort | S. A. Sterlikov |
| collection | DOAJ |
| description | The chemotherapy results have been analyzed in tuberculosis patients suffering from multiple drug resistance registered for treatment in the Russian Federation in 2011-2012 compared with the treatment outcomes of MDR patients registered for treatment in the world, BRICS and countries of the former Soviet Union in 2011. Treatment outcomes of XDR TB patients have been analyzed for the first time. Chemotherapy efficiency in MDR TB patients in the Russian Federation in the cohort of 2011 made 37.1%, and in the cohort of 2012 made 39.1%, which significantly lower than in the world in general (47.5%), in BRICS and countries of the former Soviet Union; this low treatment efficiency is mostly due to treatment failures (18.3%) and those died (19.1%). The treatment efficiency of XDR TB patients registered for treatment in the Russian Federation in 2012 made 26.2% versus 22.0% in the cohort of 2011. Considering the significant financial costs spent on the treatment, the chemotherapy efficiency of M/XDR TB patients in the Russian Federation is too low to improve the epidemic situation and some additional measures are to be taken for its improvement. |
| format | Article |
| id | doaj-art-0a9a72c5c3394e4492fbecc49f368ebc |
| institution | OA Journals |
| issn | 2075-1230 2542-1506 |
| language | Russian |
| publishDate | 2016-01-01 |
| publisher | New Terra Publishing House |
| record_format | Article |
| series | Туберкулез и болезни лёгких |
| spelling | doaj-art-0a9a72c5c3394e4492fbecc49f368ebc2025-08-20T02:05:56ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062016-01-019412227838Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the worldS. A. Sterlikov0V. V. Testov1I. A. Vasilieva2M. I. Sechenov First Moscow State Medical UniversityCentral Tuberculosis Research InstituteCentral Tuberculosis Research InstituteThe chemotherapy results have been analyzed in tuberculosis patients suffering from multiple drug resistance registered for treatment in the Russian Federation in 2011-2012 compared with the treatment outcomes of MDR patients registered for treatment in the world, BRICS and countries of the former Soviet Union in 2011. Treatment outcomes of XDR TB patients have been analyzed for the first time. Chemotherapy efficiency in MDR TB patients in the Russian Federation in the cohort of 2011 made 37.1%, and in the cohort of 2012 made 39.1%, which significantly lower than in the world in general (47.5%), in BRICS and countries of the former Soviet Union; this low treatment efficiency is mostly due to treatment failures (18.3%) and those died (19.1%). The treatment efficiency of XDR TB patients registered for treatment in the Russian Federation in 2012 made 26.2% versus 22.0% in the cohort of 2011. Considering the significant financial costs spent on the treatment, the chemotherapy efficiency of M/XDR TB patients in the Russian Federation is too low to improve the epidemic situation and some additional measures are to be taken for its improvement.https://www.tibl-journal.com/jour/article/view/838multiple drug resistant tuberculosistreatment outcomes in mdr tb patientstreatment outcomes in xdr tb patientselimination of mdr tb pool of infection |
| spellingShingle | S. A. Sterlikov V. V. Testov I. A. Vasilieva Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world Туберкулез и болезни лёгких multiple drug resistant tuberculosis treatment outcomes in mdr tb patients treatment outcomes in xdr tb patients elimination of mdr tb pool of infection |
| title | Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world |
| title_full | Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world |
| title_fullStr | Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world |
| title_full_unstemmed | Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world |
| title_short | Treatment results of patients with multiple and extensive drug resistance registered in 2012 in the Russian Federation and in the world |
| title_sort | treatment results of patients with multiple and extensive drug resistance registered in 2012 in the russian federation and in the world |
| topic | multiple drug resistant tuberculosis treatment outcomes in mdr tb patients treatment outcomes in xdr tb patients elimination of mdr tb pool of infection |
| url | https://www.tibl-journal.com/jour/article/view/838 |
| work_keys_str_mv | AT sasterlikov treatmentresultsofpatientswithmultipleandextensivedrugresistanceregisteredin2012intherussianfederationandintheworld AT vvtestov treatmentresultsofpatientswithmultipleandextensivedrugresistanceregisteredin2012intherussianfederationandintheworld AT iavasilieva treatmentresultsofpatientswithmultipleandextensivedrugresistanceregisteredin2012intherussianfederationandintheworld |